The global anti-viral drugs market is expected to grow at a CAGR of 6.9% and attain USD 62.67 Bn by the end of the forecast period of 2016-2022, asserts Market Research Future (MRFR) in an exhaustive research report.
Anti-viral drugs are used in the treatment of viral infections Growing burden of viral infections is among the prime reasons which drive the market for anti-viral drugs. Infectious diseases such as influenza, herpes, hepatitis C are among the leading causes of death worldwide. Increase incidences of epidemics in viral infection augment the demand for anti-viral drugs which boost the growth of the market.
Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/2454
Rising prevalence of HIV and other sexually transmitted diseases (STDs) assists the growth of the market. The incidence rate of HIV has seen a surge in recent years, especially in the developing countries which indicate high demand for anti-viral drugs.
Increase in the number of clinical trials has affected the market growth positively. There are a number of anti-viral drugs targeting a host of factors affecting viral replications in the early and advanced stages in clinical trials. The paucity of new anti-viral drugs will be addressed by this drug development which will eliminate the reliance on the limited number of drugs.
Besides, growing focus on R&D activities provides ample opportunities for market growth. However, the limited number of licensed anti-viral drugs and critical FDA approval and patent acquisition procedures are likely to impede the growth of the global anti-viral drugs market. Other factors impeding the growth of the market include the high cost of drug development and loss of patent of various drugs. With the expiration of many blockbuster drugs, the price of such drugs has come down considerably which has affected the market. However, loss of patent of drugs has provided growth opportunities for generics which will drive the market in the coming years.
The global anti-viral drugs market has been segmented based on mechanism of action and application. On the basis of applications, the market for anti-viral drugs is segmented based on herpes, HIV/AIDS, influenza, hepatitis, and others. Additionally, the market on the basis of mechanism of action, is segmented into nucleotide polymerase inhibitors, protease inhibitors, reverse transcriptase inhibitors, and others.
Factors like growing research and development investment and increasing incidence rates of viral infections support the anti-viral drugs market growth. The performance of anti-viral drugs market has also been studied for the past and current years. Additionally, the anti-viral drugs market report provides analysis of these segments. The anti-viral drugs market segmental analysis provided in the report offers major details about the anti-viral drugs market performance and future.
The Americas, Europe, Asia Pacific, and Middle East & Africa are the key markets for antiviral drugs. The Americas is the largest market followed by Europe. Growing prevalence of viral infections in the region, the presence of key players in the region and high healthcare expenditure drives the market in the Americas.
The Europe market is driven by the presence of a robust healthcare sector and high investment in R&D activities.
Asia Pacific is slated to be the fastest growing market for anti-viral drugs. Growing prevalence of viral infections in the developing economies of the region coupled with the outlay of massive amounts on healthcare facilities supports the growth of the Asia Pacific market
The anti-viral drugs market is supported by growing research and development investment. The population growth around the world and increasing demand of anti-viral drugs market based services and products also support the market growth. However, changes in policies and lack of clarity in guidelines can affect the market growth. The report covers all such details which will help companies in the anti-viral drugs market to strengthen their business plan and improve their product portfolio. The anti-viral drugs market research report also provides company profiles of major companies. The company profiles of many organizations operating in the anti-viral drugs market report highlights crucial details like company size, revenue growth, and details of mergers and acquisitions taking place in the anti-viral drugs market. New companies and established businesses can plan their strategies based on this data provided in the anti-viral drugs market research report.
NeuroBo Pharmaceuticals, a biotechnology firm, has announced that it has purchased ANA Therapeutics, a privately owned biotechnology company that produces a patented niclosamide capsule formulation for the indication of coronavirus, now in Phase 2/3 clinical trials as a cure for COVID-19. The deal was unanimously approved by both the Boards of Directors of NeuroBo Pharmaceuticals and ANA Therapeutics.
Table of Contents
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Global Anti-Viral Drugs Market, by Application
Browse Complete Report @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454
Related Reports Links:-
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half- Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312
Email: [email protected]